Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125977173 | 12597717 | 3 | F | 20160715 | 20160913 | 20160726 | 20160920 | PER | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-47728BP | BOEHRINGER INGELHEIM | 76.00 | YR | F | Y | 77.45000 | KG | 20160920 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125977173 | 12597717 | 1 | PS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Oral | 300 MG | Y | 22512 | 150 | MG | CAPSULE | BID | |||||
| 125977173 | 12597717 | 2 | SS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Y | 22512 | |||||||||||
| 125977173 | 12597717 | 3 | C | METOPROLOL. | METOPROLOL | 1 | Unknown | 0 | |||||||||||
| 125977173 | 12597717 | 4 | C | ATORVASTATIN | ATORVASTATIN | 1 | Unknown | 40 MG | 0 | 40 | MG | QD | |||||||
| 125977173 | 12597717 | 5 | C | ASPIRIN. | ASPIRIN | 1 | Unknown | 81 MG | 0 | 81 | MG | QD | |||||||
| 125977173 | 12597717 | 6 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | Unknown | 18 MCG | 0 | 18 | UG | INHALATION POWDER, HARD CAPSULE | QD | ||||||
| 125977173 | 12597717 | 7 | C | ALBUTEROL. | ALBUTEROL | 1 | Unknown | 0 | |||||||||||
| 125977173 | 12597717 | 8 | C | LASIX | FUROSEMIDE | 1 | Unknown | 0 | QD | ||||||||||
| 125977173 | 12597717 | 9 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Unknown | 0 | QD | ||||||||||
| 125977173 | 12597717 | 10 | C | HUMALOG | INSULIN LISPRO | 1 | Unknown | 0 | |||||||||||
| 125977173 | 12597717 | 11 | C | LANTUS | INSULIN GLARGINE | 1 | Unknown | 0 | |||||||||||
| 125977173 | 12597717 | 12 | C | TRAMADOL. | TRAMADOL | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125977173 | 12597717 | 1 | Cerebrovascular accident prophylaxis |
| 125977173 | 12597717 | 2 | Atrial fibrillation |
| 125977173 | 12597717 | 3 | Hypertension |
| 125977173 | 12597717 | 4 | Hyperlipidaemia |
| 125977173 | 12597717 | 5 | Cardiac disorder |
| 125977173 | 12597717 | 6 | Chronic obstructive pulmonary disease |
| 125977173 | 12597717 | 7 | Chronic obstructive pulmonary disease |
| 125977173 | 12597717 | 8 | Product used for unknown indication |
| 125977173 | 12597717 | 9 | Product used for unknown indication |
| 125977173 | 12597717 | 10 | Chronic obstructive pulmonary disease |
| 125977173 | 12597717 | 11 | Chronic obstructive pulmonary disease |
| 125977173 | 12597717 | 12 | Chronic obstructive pulmonary disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125977173 | 12597717 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125977173 | 12597717 | Haemorrhoids | |
| 125977173 | 12597717 | Rectal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125977173 | 12597717 | 1 | 20160708 | 20160715 | 0 |